TY - JOUR
T1 - The European artificial intelligence strategy
T2 - implications and challenges for digital health
AU - Cohen, I. Glenn
AU - Evgeniou, Theodoros
AU - Gerke, Sara
AU - Minssen, Timo
N1 - Funding Information:
IGC, SG, and TM were supported by a grant from the Collaborative Research Program for Biomedical Innovation Law, a scientifically independent collaborative research program supported by a Novo Nordisk Foundation grant (NNF17SA0027784). IGC served as a bioethics consultant for Otsuka on their Abilify MyCite product. The company neither funded the preparation of this Viewpoint nor played a role in its drafting or review. SG received funding from the German Federal Ministry of Education and Research, from April 1, 2016, to March 31, 2018, outside the submitted work. TM reports grants from the University of Copenhagen and the Wallenberg Foundation, outside the submitted work; and a part-time advisor in legal matters role for X-officio. TE declares no conflict of interests.
Publisher Copyright:
© 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license
PY - 2020/7
Y1 - 2020/7
N2 - In February, 2020, the European Commission published a white paper on artificial intelligence (AI) as well as an accompanying communication and report. The paper sets out policy options to facilitate a secure and trustworthy development of AI and considers health to be one of its most important areas of application. We illustrate that the European Commission's approach, as applied to medical AI, presents some challenges that can be detrimental if not addressed. In particular, we discuss the issues of European values and European data, the update problem of AI systems, and the challenges of new trade-offs such as privacy, cybersecurity, accuracy, and intellectual property rights. We also outline what we view as the most important next steps in the Commission's iterative process. Although the European Commission has done good work in setting out a European approach for AI, we conclude that this approach will be more difficult to implement in health care. It will require careful balancing of core values, detailed consideration of nuances of health and AI technologies, and a keen eye on the political winds and global competition.
AB - In February, 2020, the European Commission published a white paper on artificial intelligence (AI) as well as an accompanying communication and report. The paper sets out policy options to facilitate a secure and trustworthy development of AI and considers health to be one of its most important areas of application. We illustrate that the European Commission's approach, as applied to medical AI, presents some challenges that can be detrimental if not addressed. In particular, we discuss the issues of European values and European data, the update problem of AI systems, and the challenges of new trade-offs such as privacy, cybersecurity, accuracy, and intellectual property rights. We also outline what we view as the most important next steps in the Commission's iterative process. Although the European Commission has done good work in setting out a European approach for AI, we conclude that this approach will be more difficult to implement in health care. It will require careful balancing of core values, detailed consideration of nuances of health and AI technologies, and a keen eye on the political winds and global competition.
UR - http://www.scopus.com/inward/record.url?scp=85087081850&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85087081850&partnerID=8YFLogxK
U2 - 10.1016/S2589-7500(20)30112-6
DO - 10.1016/S2589-7500(20)30112-6
M3 - Review article
C2 - 33328096
AN - SCOPUS:85087081850
SN - 2589-7500
VL - 2
SP - e376-e379
JO - The Lancet Digital Health
JF - The Lancet Digital Health
IS - 7
ER -